KYPROLIS® (carfilzomib) Patents Upheld Against Generic Manufacturer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. DOCU
6. ASAN
7. CIEN
8. SPY
9. GWRE
10. CPB

Go back to KYPROLIS® (carfilzomib) Patents Upheld Against Generic Manufacturer
Amgen Inc (NASDAQ: AMGN) Delayed: 444.12 --0 (-0%)
Previous Close $444.12    52 Week High $176.85 
Open $444.12    52 Week Low $133.64 
Day High $444.12    P/E 66.89 
Day Low $444.12    EPS $6.64 
Volume 2,347